Icosavax's market cap is currently ―. The company's EPS TTM is $-2.22; its P/E ratio is -6.89; Icosavax is scheduled to report earnings on March 28, 2024, and the estimated EPS forecast is $-0.51. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	-	-	-	-	$ 0.00
Gross Profit	-	-	-	$ 582.00K	-
EBIT	$ -22.02M	$ -26.50M	$ -26.18M	$ -26.44M	$ -23.14M
EBITDA	$ -22.73M	$ -26.95M	$ -26.59M	$ -26.58M	$ -23.00M
Net Income Common Stockholders	$ -22.02M	$ -26.50M	$ -24.22M	$ -23.41M	$ -21.98M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 229.21M	$ 246.93M	$ 197.65M	$ 219.37M	$ 221.40M
Total Assets	$ 251.30M	$ 269.03M	$ 219.67M	$ 238.68M	$ 243.88M
Total Debt	$ 8.07M	$ 8.44M	$ 8.80M	$ 8.79M	$ 6.68M
Net Debt	$ -221.13M	$ -238.49M	$ -188.85M	$ -210.57M	$ -214.72M
Total Liabilities	$ 18.92M	$ 21.30M	$ 19.59M	$ 20.52M	$ 18.21M
Stockholders Equity	$ 232.38M	$ 247.72M	$ 200.08M	$ 218.16M	$ 225.66M
Cash Flow	-
Free Cash Flow	$ -19.00M	$ -19.90M	$ -23.22M	$ -11.55M	$ -21.33M
Operating Cash Flow	$ -18.97M	$ -19.22M	$ -21.65M	$ -9.00M	$ -17.38M
Investing Cash Flow	$ -72.65M	$ 55.82M	$ 12.03M	$ -6.74M	$ -26.18M
Financing Cash Flow	$ -208.00K	$ 68.07M	$ 117.00K	$ 10.09M	$ -279.00K

Currency in USD

Icosavax Earnings and Revenue History

Income Statement >

Icosavax Debt to Assets

Balance Sheet >

Icosavax Cash Flow

Cash Flow >

Icosavax Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing